Synopsis

It is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO, and the first to be done in a single injection.WHO approves Johnson & Johnson’s one-shot Covid-19 vaccine for emergency useThe World Health Organization has approved the emergency-use listing of Johnson & Johnson’s COVID-19 vaccine, the U.N. agency said on Friday, broadening access to the shots.

It is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and

to receive backing from the WHO, and the first to be done in a single injection.

The listing covers use in all countries and for roll-out of the vaccine platform COVAX and comes on the back of European Medicines Agency (EMA) authorisation announced on Thursday.

“Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.

“But the hope offered by these tools will not materialise unless they are made available to all people in all countries.”

The WHO also welcomed the one-shot administration as facilitating vaccination logistics.

J&J’s chief scientist Paul Stoffels told Reuters on Thursday the company expects to produce up to 3 billion doses of the vaccine next year, after previously pledging to deliver 1 billion globally by the end of 2021.

The WHO said that, under an emergency-use listing, companies have to commit to generate further safety and efficacy data to enable full licensing.

( Originally published on Mar 12, 2021 )

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)Download The Economic Times News App to get Daily Market Updates & Live Business News.

3 Comments on this StorySubbu India3 days ago

We will be happy if J&J covid vaccine is introduced in India especially because this is one shot vaccine.

ADISESHU Simhadri3 days ago

Whether the vaccines of various brands that are already put to use to fight COVID-19, are tested and proved 100 per cent effective? If so, why the authorities are not publicising the findings in the public domain to infuse confidence in various age groups and with existing deceases?

Ganesh Shelke3 days ago

Why every company put their efforts separately to make vaccine instead all companies and their R&D team come together and make 100% effective vaccine. Think humanity instead of business.